China Artificial Intelligence in Healthcare Market Size, Scope 2024-2032

MaliyahBusiness2025-07-298510

China Artificial Intelligence (Ai) in Healthcare Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 23.50% (2024-2032)

Rapid improvements in machine learning (ML) algorithms, natural language processing, and computer vision are making artificial intelligence (AI) applications capable of handling complex healthcare tasks in China. According to IMARC Group, China artificial intelligence (AI) in healthcare market is projected to exhibit a growth rate (CAGR) of 23.50% during 2024-2032.

Download sample copy of the Report: https://www.imarcgroup.com/china-artificial-intelligence-in-healthcare-market/requestsample

China Artificial Intelligence in Healthcare Industry Trends and Drivers:

Rapid improvements in machine learning (ML) algorithms, natural language processing, and computer vision is making artificial intelligence (AI) applications capable of handling complex healthcare tasks in China. These innovations are enabling the development of AI-powered tools for diagnostics, predictive analytics, and personalized treatment plans. Besides this, the proliferation of high-speed internet and 5G technology across China is providing the necessary infrastructure for seamless data transfer and real-time AI processing, further propelling the market growth.

Moreover, domestic and international healthcare companies, technology firms, and venture capitalists are investing in AI startups and projects, which is strengthening the market growth. Collaborations between hospitals, research and development (R&D) institutions, and tech companies are fostering innovations and accelerating AI applications in healthcare, bridging the gap between technological advancements and practical healthcare needs.

Moreover, the growing focus on precision medicine and personalized care is positively influencing the market, as AI is enabling the analysis of large datasets to create customized treatment plans, thereby improving patient outcomes. Governing agencies of the country are also prioritizing AI in its national development plans and strategic initiatives, aiming to position China as a global leader in AI technology. This commitment includes substantial investments in AI research and development (R&D) activities and fostering public-private partnerships to facilitate AI integration into healthcare.

In addition, there is a rise in the number of elderly individuals, which is driving the demand for healthcare services capable of managing chronic diseases and age-related conditions efficiently. AI technologies are offering solutions like remote monitoring, predictive analytics for disease management, and automated support systems, which are helping reduce the burden on healthcare professionals and improving care for the elderly. This demographic shift is encouraging healthcare providers to adopt AI technologies and enhance service delivery while managing resources effectively. Furthermore, AI technologies are automating routine tasks, optimizing resource allocation, and streamlining administrative processes, which is offering a favorable market outlook in the country.

China Artificial Intelligence in Healthcare Industry Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest China Artificial Intelligence in Healthcare Market share. It includes forecasts for the period 2024-2032 and historical data from 2018-2023 for the following segments.

The report has segmented the market into the following categories:

Offering Insights:

Hardware

Software

Services

Technology Insights:

Machine Learning

Context-Aware Computing

Natural Language Processing

Others

Application Insights:

Robot-Assisted Surgery

Virtual Nursing Assistant

Administrative Workflow Assistance

Fraud Detection

Dosage Error Reduction

Clinical Trial Participant Identifier

Preliminary Diagnosis

Others

End User Insights:

Healthcare Providers

Pharmaceutical and Biotechnology Companies

Patients

Others

Region Insights:

North China

East China

South Central China

Southwest China

Northwest China

Northeast China

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

Market Performance (2018-2023)

Market Outlook (2024-2032)

COVID-19 Impact on the Market

Porter’s Five Forces Analysis

Strategic Recommendations

Historical, Current and Future Market Trends

Market Drivers and Success Factors

SWOT Analysis

Structure of the Market

Value Chain Analysis

Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email'protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145

 

Post a message

您暂未设置收款码

请在主题配置——文章设置里上传